RBC Capital Maintained a Buy on BioCryst Pharmaceutical (BCRX), Sets a PT of $13

admin_news

Jul 14, 2025 - 09:30

0 0

RBC Capital Maintained a Buy on BioCryst Pharmaceutical (BCRX), Sets a PT of $13

What's Your Reaction?

Like 0

Dislike 0

Love 0

Funny 0

Angry 0

Sad 0

Wow 0

Related Posts

Nvidia: AI boom not dead yet

admin_news Feb 27, 2025 0 0

Stock Futures Rebounding Ahead of Key Nvidia Earnings

admin_news Feb 27, 2025 0 0

Factbox-Where does the US get its copper?

admin_news Feb 27, 2025 0 0

Nvidia sells $11 billion of next-gen Blackwell AI chips...

admin_news Feb 27, 2025 0 0

Bitcoin ETFs are hit by a record $1 billion outflow in ...

admin_news Feb 27, 2025 0 0

From fashion to cars, Russian markets pose new test for...

admin_news Feb 27, 2025 0 0

Comments

google.com, pub-7219625775647229, DIRECT, f08c47fec0942fa0